Sight Sciences, Inc.

SGHT· Nasdaq· Surgical & Medical Instruments & Apparatus

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
-38.7%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+22.9%
We record prices for the companies we cover; SGHT is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
52.1M
Revenue
$77.4M
Free cash flow
-$29.9M
Owner earnings
-$43.0M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
86.2%
Operating
-48.0%
Net
-49.7%
Free cash flow
-38.7%
Owner earnings
-55.5%
Stock pay
16.9%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
-60.1%
ROE, 5 yr avg
-49.2%

Growth (CAGR)

Revenue, 3 yr
2.7%
Revenue, 5 yr
22.9%
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–

Financial health · FY2025

Cash and investments
$92.0M
Total debt
$40.3M
Net cash
$51.7M
Debt/Equity
0.6x
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
–

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$77.4M

+22.9% a year over 5 years

FY2020: Revenue $27.6MFY2021: Revenue $49.0MFY2022: Revenue $71.3MFY2023: Revenue $81.1MFY2024: Revenue $79.9MFY2025: Revenue $77.4M
FY2020FY2025

Margins

Gross86.2%Operating-48.0%Net-49.7%

FY2025

FY2020: Gross 66.7%, Operating -116.5%, Net -125.5%FY2021: Gross 82.4%, Operating -105.2%, Net -128.6%FY2022: Gross 82.7%, Operating -117.7%, Net -120.9%FY2023: Gross 85.3%, Operating -70.7%, Net -68.5%FY2024: Gross 85.5%, Operating -63.3%, Net -64.5%FY2025: Gross 86.2%, Operating -48.0%, Net -49.7%
FY2020FY2025

Free cash flow and owner earnings

Free cash flow-$29.9MOwner earnings-$43.0M

FY2025

FY2020: Free cash flow -$33.1M, Owner earnings -$33.6MFY2021: Free cash flow -$53.4M, Owner earnings -$58.4MFY2022: Free cash flow -$76.9M, Owner earnings -$89.9MFY2023: Free cash flow -$48.0M, Owner earnings -$62.6MFY2024: Free cash flow -$22.7M, Owner earnings -$39.8MFY2025: Free cash flow -$29.9M, Owner earnings -$43.0M
FY2020FY2025

Diluted shares

52.1M

+95.1% over 5 years, net dilution

FY2020: Diluted shares –FY2021: Diluted shares 26.7MFY2022: Diluted shares 47.8MFY2023: Diluted shares 48.6MFY2024: Diluted shares 50.1MFY2025: Diluted shares 52.1M
FY2020FY2025

Net cash

$51.7M

$51.7M more cash than debt

FY2020: Net cash $29.6MFY2021: Net cash $228.0MFY2022: Net cash $151.7MFY2023: Net cash $104.2MFY2024: Net cash $81.0MFY2025: Net cash $51.7M
FY2020FY2025

Every figure, year by year

Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$27.6M$49.0M$71.3M$81.1M$79.9M$77.4M
Revenue growth–77.1%45.7%13.6%-1.5%-3.1%
Gross margin66.7%82.4%82.7%85.3%85.5%86.2%
Operating margin-116.5%-105.2%-117.7%-70.7%-63.3%-48.0%
Net income-$34.7M-$63.0M-$86.2M-$55.5M-$51.5M-$38.4M
Net margin-125.5%-128.6%-120.9%-68.5%-64.5%-49.7%
Diluted EPS–$-2.36$-1.80$-1.14$-1.03$-0.74
Return on invested capital?––––––
Cash
Operating cash flow-$32.2M-$52.5M-$76.0M-$47.2M-$22.4M-$29.7M
Capital expenditure$953.0K$813.0K$970.0K$791.0K$385.0K$224.0K
Free cash flow-$33.1M-$53.4M-$76.9M-$48.0M-$22.7M-$29.9M
Stock-based compensation$497.0K$5.1M$13.0M$14.6M$17.1M$13.1M
Owner earnings?-$33.6M-$58.4M-$89.9M-$62.6M-$39.8M-$43.0M
Free cash flow per share–$-2.00$-1.61$-0.99$-0.45$-0.57
Capital allocation
Dividends paid––––––
Share repurchases––––––
Diluted shares–26.7M47.8M48.6M50.1M52.1M
Share count change?––79.0%1.6%3.1%4.0%
Balance sheet
Cash and equivalents$61.5M$260.7M$185.0M$138.1M$120.4M$92.0M
Short-term investments––––––
Total debt$32.0M$32.7M$33.3M$33.9M$39.4M$40.3M
Net debt-$29.6M-$228.0M-$151.7M-$104.2M-$81.0M-$51.7M
Shareholders' equity-$88.8M$232.1M$160.1M$120.2M$87.5M$63.9M

Latest filings

All on EDGAR
2026-08-0510-QQuarterly report
2026-08-058-KEarnings release
2026-05-0610-QQuarterly report
2026-05-068-KEarnings release
2026-04-22DEF 14AProxy statement
2026-03-0410-KAnnual report
2026-03-048-KEarnings release
2026-01-138-KEarnings release
2025-11-0610-QQuarterly report
2025-11-068-KEarnings release

More from our coverage

All coverage